LEGALDIGMLEGALDIGM
    ← Code of Federal Regulations
    Beta
    21 CFR § 866.3945

    21 CFR § 866.3945 — § 866.3945 Dengue virus serological reagents.

    Beta. Legal information, not legal advice. LEGALDIGM is not a law firm. Check the official source for the current text.

    Analyze this law with AI
    § 866.3945 Dengue virus serological reagents. (a) Identification. Dengue virus serological reagents are devices that consist of antigens and antibodies for the detection of dengue virus and dengue antibodies in individuals who have signs and symptoms of dengue fever or dengue hemorrhagic fever. The detection aids in the clinical laboratory diagnosis of dengue fever or dengue hemorrhagic fever caused by dengue virus. (b) Classification. Class II (special controls). The special control is FDA's guideline entitled “Class II Special Controls Guideline: Dengue Virus Serological Reagents.” For availability of the guideline document, see § 866.1(e). [79 FR 31023, May 30, 2014]

    Related guides, FAQ and contract templates